PATENT CLAIM ANALYSIS

Application Number: 15866744
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-05
Patent Classification: ["514", "180000"]

Abstract:
The present invention aims to provide an eye drop for treating macular edema. The present invention provides an eye drop for treating macular edema, which contains difluprednate as an active ingredient. The eye drop can afford effects such as improvement of visual acuity and decreased foveal retinal thickness in macular edema.

Claim (Index 63):
The method according to  claim 55 , wherein the emulsion eye drop is administered 4 times per day for 4 weeks from the start of the administration and twice per day after 4 weeks, in a dose of 30-50 \u03bcL per administration.

Metadata:
- Claim Count in Document: 41.0
- Percentile: 86.0
- Lexical Diversity: 1.52778
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14661295', '13940370', '15471506', '11695527', '14972560']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7724646781136033
- 35 USC 102 Novelty (BERT): 0.666541437118341
- Combined Prediction Score: 0.761872354014077
- Mean Citation Score: 323.74317600000006
- Max Citation Score: 652.79486
- Similarity Product: 636.9488452425622

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test